Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.34 |
| ▸ | CNR1 | P21554 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL358493 | 1.00 | TDP1 (0.51) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL9453382 | 0.89 | TDP1 (0.51) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL13483229 | 0.89 | TDP1 (0.55) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL13810599 | 0.89 | TDP1 (0.55) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL14121616 | 0.88 | TDP1 (0.55) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL14121614 | 0.88 | TDP1 (0.55) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL1815554 | 0.88 | TDP1 (0.54) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL2058737 | 0.88 | TDP1 (0.65) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL10056746 | 0.88 | TDP1 (0.54) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL10056745 | 0.88 | TDP1 (0.54) | TDP1MEN1KMT2ALMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8461370-B2 | Process for producing 3-(2-cyano-1-propenyl)-2,2- dimethylcyclopropanecarboxylic acid or salt thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-06-11 | — | — | US | disclosed |
| EP-2537828-A1 | METHOD FOR PRODUCING CYANOALKENYLCYCLOPROPANECARBOXYLIC ACID SALT | Sumitomo Chemical Company, Limited (JP) | 2012-12-26 | — | — | EP | disclosed |
| US-20120310003-A1 | METHOD FOR PRODUCING CYANOALKENYLCYCLOPROPANECARBOXYLIC ACID SALT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-12-06 | — | — | US | disclosed |
| US-20120016150-A1 | Process for Producing 3-(2-Cyano-1-propenyl)-2,2- Dimethylcyclopropanecarboxylic Acid or Salt Thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-01-19 | — | — | US | disclosed |
| US-7662988-B2 | Ester compound and its use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-02-16 | — | — | US | disclosed |
| US-7662988-B2 | Ester compound and its use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-02-16 | — | — | US | disclosed |
| US-20090170936-A1 | Ester Compound and Its Use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-07-02 | — | — | US | disclosed |
| US-20090170936-A1 | Ester Compound and Its Use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120310003-A1 | METHOD FOR PRODUCING CYANOALKENYLCYCLOPROPANECARBOXYLIC ACID SALT | MCCC2, AOC2, DDC | TDP1 3723/4885MEN1 2951/4885KMT2A 1178/4885 |
| US-20090170936-A1 | Ester Compound and Its Use | CYP51A1, CYP46A1, CES1 | TDP1 3013/4885MEN1 1586/4885KMT2A 1089/4885 |
| US-20120016150-A1 | Process for Producing 3-(2-Cyano-1-propenyl)-2,2- Dimethylcyclopropanecarboxylic Acid or Salt Thereof | CPS1, PCCA, PKD1 | TDP1 3167/4885MEN1 1087/4885KMT2A 1950/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.